[1]
Sanchez Aranda, C. et al. 2024. Methotrexate might become the sole treatment option for leukemia following the occurrence of Stevens–Johnson syndrome. Allergologia et Immunopathologia. 52, 4 (Jul. 2024), 81–83. DOI:https://doi.org/10.15586/aei.v52i4.983.